Physicians are best positioned to curtail the $265 billion wasted annually on unneeded care.
As merger activity heightens, some leverage retail with pharma to meet consumer demand.
Those challengers who address critical patient needs beyond traditional treatment will become a force to be reckoned with.
From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.
How pharmaceutical companies can better define, measure, and deliver value to patients.
The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.
Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?
Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.
A discussion on how mega mergers affect consumers and how consolidation is driving the new future of healthcare.
2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.